Product Manager - Limbic Access

Limbic builds AI-powered mental healthcare. Our front-door Access product talks to thousands of patients a month across the NHS and major US health systems. Access is past 0→1 in the UK and US: the product exists, customers are live, the model is proven. We're hiring a Product Manager to take it 1→10 in the US, against a growing pipeline of enterprise customers, owning the team's day-to-day product cadence. The job is to ship and ship well.

What You'll Own

You'll own the week-to-week rhythm that turns engineering into shipped product:

Run the team's ceremonies: effective, alignment-creating, always followed up on.
Own roadmap prioritisation. Understand the projects in play, weigh their relative impact, and sequence them. Ground the sequencing in customer signal, and user feedback, usage, and behaviour.
Triage the inbound: bugs, debt, CS asks, scope additions. Separate real issues from noise, route to the right owner, decide what gets iterated when.
Scope and define the work. Write project overviews the team can act on, ensuring the next-highest-value project is always lined up.
Own the incident loop. Triage, root cause, fix, follow-up. Engineers get space to fix; you hold the loop.
Keep the product well instrumented. Mixpanel today and whatever's next. Ensure the team can answer its own questions from the data, and that you can read user behavior out of it.
Protect engineering focus. Hold the line on scope creep from any sources. Check in 1:1 mid-cycle with anyone who's blocked or drifting.

What We're Looking For

You've shipped product before. Maybe one or two roles in. You want real product management. The kind where you own outcomes, not Jira tickets.

You ship features and projects that move metrics and create outcomes. Not work that's about looking good.
Comfortable with engineers and engineering concepts. You build strong mental models for how products work and apply them in your day-to-day.
You write clearly and quickly. You think clearly from first principles.
You think critically with data. You can pull insights yourself, interrogate how they were generated, and reason about what they actually mean. Not 'I made a decision with data once.'
You never produce AI slop, but you do heavily rely on AI in your day-to-day. You go beyond using AI to write PRDs.
You are 'client safe' - you can represent Limbic to customers professionally.
You can say no to someone and make them feel it's in their best interest.
You build products. You know the difference between a feature that creates repeatable value and a one-off that introduces drag and tech debt.
Healthcare experience is a bonus, but not a requirement. EHR integration and working knowledge of health-data standards (HL7, FHIR) especially.

You won't fit if you need polished process, a heavy spec phase, or a team that loves meetings. We're ahead of our process.

Why This Role

Two things to know.

One. It's a delivery role for now, with a clear set of projects to execute on (but prioritize and sequence effectively). You'll grow into more strategic scope over the next 4-6 months. The immediate brief is to make the engineering team's product cadence quieter and more predictable.

Two. The team is small and load is high. The hire exists because we need to free senior product time for discovery and strategy on a separate product. You might feel the pressure of that. In return: real customers (millions of lives) and the opportunity to iterate the product in a company-defining direction.

Practical

Level: APM / Mid Product Manager
Location: East Coast USA

About the company

Limbic develops clinical-grade AI software for mental healthcare and sells it as SaaS to NHS organizations and other health systems in the UK and US. Its main products are Limbic Access, an AI chatbot for intake, screening, data collection, and risk flagging, and Limbic Care, a generative AI companion for CBT-based activities between therapy sessions. A key differentiator is regulatory clearance (Class IIa UKCA) and its proprietary Limbic Layer, which sits between the user and a large language model to ensure interactions follow validated clinical guidance. The company collaborates with NHS Mental Health Services to co-design its tools and aims to broaden access and efficiency in mental health care, with ongoing expansion into the US market.

Company Size

1-10

Company Stage

Series A

Total Funding

$14.2M

Headquarters

London, United Kingdom

Founded

2013

Get referred to Limbic

See people who can refer or advise you

Simplify's Take

What believers are saying

August 2026 TEMPO gives Unpacked Medicare access and real-world evidence collection.
March 2026 Nature Medicine data showed stronger CBT performance than human therapists.
The March 2024 $14 million Khosla round funds U.S. expansion and commercialization.

What critics are saying

TEMPO is a pilot; FDA and CMS can stall, narrow, or terminate Unpacked quickly.
If Unpacked safety signals disappoint, clinicians, payers, and regulators will shut adoption.
Limbic’s NHS-heavy revenue base faces procurement delays and budget scrutiny through 2027.

What makes Limbic unique

Limbic’s Class IIa UKCA and FDA TEMPO selection separate it from generic chatbot vendors.
Its Limbic Layer constrains LLM outputs to validated clinical guidance, not free-form generation.
By September 2026, NHS deployments and 260,000-plus patients prove workflow integration at scale.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Stock Options
Company Equity
Paid Vacation
Hybrid Work Options
Flexible Work Hours
Parental Leave
Mental Health Support
Paid Holidays

Company News

Yahoo Finance

Aug 19th, 2026

Limbic becomes first AI mental healthcare firm in FDA TEMPO pilot for Medicare patients

Limbic has become the first AI-led mental healthcare company selected for the US Food and Drug Administration's TEMPO pilot programme. Through the initiative, Limbic will introduce Unpacked, a clinician-supervised AI mental health service for Medicare beneficiaries with depression or anxiety. The service delivers cognitive behavioural therapy through scheduled telephone conversations with an AI voice agent, overseen by licensed clinicians. AI agents conduct CBT sessions between clinician contacts, whilst clinicians review patient progress, receive real-time safety alerts, and can adjust treatment as needed. The TEMPO pilot allows manufacturers to offer new technologies whilst gathering real-world data for FDA evaluation. Across Medicare and Medicaid combined, providers are unable to accept new patients, mainly due to full caseloads. Unpacked aims to address this gap by providing immediate access to clinically-supported care.

Business Wire

Mar 12th, 2026

AI therapy agents outperform human therapists in cognitive behavioral therapy, Nature Medicine study finds

Limbic, a clinical mental health AI company, has published a randomised, double-blind study in Nature Medicine showing its AI therapy system outperforms human therapists in delivering cognitive behavioural therapy. The system combines leading large language models with Limbic's clinical reasoning layer. The study evaluated 227 participants across licensed therapists, standalone LLMs and LLMs with Limbic's layer. Results showed 74.3% of AI-powered sessions scored higher than the top 10% of human sessions, with AI agents scoring 43% higher than standalone LLMs on the Cognitive Therapy Rating Scale. Clinicians preferred the enhanced AI agents 82.7% of the time. A real-world analysis of 19,674 therapy transcripts showed users with highest exposure to Limbic's system achieved a 51.7% recovery rate, compared to 32.8% for lower exposure groups.

Digital Health

Dec 16th, 2025

NHS Confederation and Limbic explore AI use in mental health

NHS Confederation and Limbic explore AI use in mental health. Rebecca Gray, director of the NHS Confederation's Mental Health Network (Credit: NHS Confederation) * The NHS Confederation and Limbic have partnered to explore how AI can improve mental health services * The project will identify the barriers and opportunities facing NHS systems related to AI use and long-term adoption in mental health care * Limbic was announced as the first-ever winner in the scale-up category of Digital Health Rewired Pitchfest in 2023 Former Pitchfest winner Limbic has partnered with the NHS Confederation to explore how AI can improve mental health services and access to care. Limbic was announced as the first-ever winner in the scale-up category of Digital Health Rewired Pitchfest in 2023 for its AI mental health chatbot. The NHS Confed Mental Health Network will work with Limbic to identify the barriers and opportunities facing NHS systems related to AI use and long-term adoption in mental health care. Rebecca Gray, director of the NHS Confederation's Mental Health Network, said: "The 10 year health plan sets out a vision for a health service that embraces digital and AI to improve access and the effectiveness of care. "The rise of AI-enabled tools presents both opportunities and challenges. Issues of safety, effectiveness, accessibility and a lack of guidance mean that there is a real need for support in this area. "Digital Health is delighted to be working with Limbic, whose wealth of experience and expertise will help to ensure that science and evidence underpin the adoption of AI in mental health services. "We need to give members the confidence to make informed decisions focused on the biggest areas of need, sharing practical examples of what works, and ensuring that AI strengthens services rather than adding unnecessary complexity." The project will also provide practical guidance on AI adoption, supported by case studies and examples of use in mental health, and support systems looking to expand their use of AI tools and create an environment in which they can thrive. Ross Harper, chief executive and founder of Limbic, said: "Digital Health know that AI has enormous potential to scale mental healthcare, but realising that potential requires collaboration, evidence, and a problem-first approach. "Our partnership with the NHS Confederation positions us at the heart of this critical conversation, helping shape how clinical AI can genuinely improve outcomes for patients and clinicians alike." Kathleen Henrick, UK general manager at Limbic, said: "Mental health services are under enormous pressure, and AI offers tangible solutions, but only when implemented safely and effectively. "Digital Health is delighted to partner with the NHS Confederation's Mental Health Network to ensure mental health leaders have the practical guidance and evidence they need to deploy clinical AI confidently and responsibly. "By sharing its experience from deployments across the NHS and learning from mental health leaders, Digital Health can ensure AI adoption is guided by clinical need and patient safety. "Together, we can move beyond the hype and focus on regulated clinical AI solutions that deliver measurable value across the care pathway."

PYMNTS

Apr 10th, 2024

Mental Health Sector Is Adopting Ai-Powered Apps For Accessible Care

The mental health arena is buzzing with the entry of AI-powered apps that promise fast and accessible care. Amid soaring demand for mental health support, artificial intelligence (AI) apps are sparking debate among experts. These tools offer hope for bridging care gaps but come with concerns over efficacy and ethics. As the field navigates this digital wave, experts say the challenge lies in determining whether AI can genuinely complement the human touch in mental health care or if it serves merely as a high-tech stopgap. “AI is incredibly useful for mental health apps because it can personalize care at scale, offering tailored support and interventions based on individual user data,” Derek Du Chesne, CEO of Better U, a mental wellness company, and creator of the Better U mental wellness app and patient portal, told PYMNTS

VCBay

Mar 6th, 2024

U.S.A. And Uk-Based Limbic Raises Usd 14 Million In Funding

N.Y.C., U.S.A. and London, United Kingdom-based leading clinical mental health A.I. technology company Limbic raised USD 14 million. The company announced the fundraising on March 5, 2024. Khosla Ventures led the financing for the company. Meanwhile, new investors, such as Gaingels, an LGBTQIA+/Allies investment syndicate, and Illusian, the family office of Ilkka Paananen, co-founder of Supercell, joined the round.Purpose of financing for LimbicThe funding seeks to expand the availability of Limbic’s clinical mental health A.I

Limbic

Product Manager

About the job